Correlation of T-helper secretory differentiation and types of antigen- presenting cells in squamous intraepithelial lesions of the uterine cervix

Journal of Pathology

Volumn 184, Issue 3, 1998, Pages 283-290

  Al Saleh, Walid ^a   Giannini, Sandra L ^a   Jacobs, Nathalie ^a   Moutschen, Michel ^a   Doyen, Jean ^a   Boniver, Jacques ^a   Delvenne, Philippe ^a,b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CHU SART TILMAN   (Belgium)

Author keywords

Antigen presenting cells; Cytokines; Human papillomavirus; Squamous intraepithelial lesions; T lymphocytes; Uterine cervix

Indexed keywords

CD1 ANTIGEN; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6;

ANTIGEN PRESENTING CELL; ARTICLE; BASOPHIL; CANCER GRADING; CONTROLLED STUDY; FEMALE; HELPER CELL; HUMAN; HUMAN TISSUE; KERATINOCYTE; LANGERHANS CELL; LYMPHOCYTE DIFFERENTIATION; MAST CELL; PRECANCER; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU;

ANTIGEN-PRESENTING CELLS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTOKINES; DISEASE PROGRESSION; FEMALE; HLA-DR ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-2; INTERLEUKIN-4; PAPILLOMAVIRIDAE; PRECANCEROUS CONDITIONS; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH2 CELLS; UTERINE CERVICAL NEOPLASMS;

EID: 0031939296     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199803)184:3<283::AID-PATH25>3.0.CO;2-K     Document Type: Article

References (44)

1. Parkin D, Läärä E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988; 41: 184-197.
2. Richart RM. Cervical intraepithelial neoplasia. In: Sommers SC, ed. Pathology Annual. New York: Appleton-Century-Crofts, 1973; 301-328.
3. NCI Workshop. The 1988 Bethesda system for reporting cervical/vaginal cytological diagnoses. J Am Med Assoc 1989; 262: 931-934.
4. Dyson N, Howley PM, Munger K, Harlow E. The human papillomavirus-16 E7 oncoprotein is able to bind the retinoblastoma gene product. Science 1989; 243: 934-937.
5. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990; 248: 76-79.
6. von Knebel Doeberitz M, Rittmuller C, zur Hausen H, Durst M. Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6-E7 anti-sense RNA. Int J Cancer 1992; 51: 831-834.
7. Jochmus-Kudielka I, Scheinder A, Braun R, et al. Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity and cervical cancer. J Natl Cancer Inst 1989; 81: 1698-1704.
8. Bleul C, Muller M, Frank R, et al. Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients. J Clin Microbiol 1991; 29: 1579-1588.
9. Benton C, Shahidullah H, Hunter JAA. Human papillomavirus in the immunosuppressed. Papillomavirus Rep 1992; 3: 23-26.
10. Altmann A, Jochmus-Kudielka I, Frank R, et al. Definition of immunogenic determinants of the human papillomavirus type 16 nucleoprotein E7. Eur J Cancer 1992; 28: 326-333.
11. MacLean CS, Sterling JS, Mowat J, Nash AA, Stanley MA. Delayed-type hypersensitivity response to the human papillomavirus type-16 E7 protein in a mouse model. J Gen Virol 1993; 74: 239-245.
12. Aiba S, Rokugo M, Tagami H. Immunohistologic analysis of the phenomenon of spontaneous regression of numerous flat warts. Cancer 1986; 58: 1246-1251.
13. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted protein. J Immunol 1986; 136: 2348-2357.
14. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994; 12: 227-257.
15. Maggi E, Parronchi P, Manetti R, et al. Reciprocal regulatory effects of IFNγ and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol 1992; 148: 2142-2147.
16. Le Gros G, Ben-Sasson SZ, Seder R, Finkelman FD, Paul WE. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: 1L-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J Exp Med 1990; 172: 921-929.
17. Bradding P, Feather IH, Howarth PH, et al. Interleukin-4 is localised to and released by human mast cells. J Exp Med 1992; 176: 1381-1386.
18. Brunner T, Heusser CH, Dahinden CA. Human peripheral blood basophils primed by interleukin-3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med 1993; 177: 605-611.
19. Nonaka M, Nonaka R, Woolley K, et al. Distinct immunohistochemical localization of IL-4 in human inflamed airway tissues. IL-4 is localized to eosinophils in vivo and is released by peripheral blood eosinophils. J Immunol 1995; 155: 3234-3244.
20. Nickoloff JB, Turka LA. Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol Today 1994; 15: 464-469.
21. Delvenne P, Engellenner WJ, Fu Ma S, Mann WJ, Chalas E, Nuovo GJ. Detection of human papillomavirus DNA in biopsy proven cervical intraepithelial lesions in pregnant women. J Reprod Med 1992; 37: 829-833.
22. Delvenne P, Fontaine MA, Delvenne C, Nikkels A, Boniver J. Detection of human papillomaviruses in paraffin-embedded biopsies of cervical intraepithelial lesions. Analysis by immunohistochemistry, in situ hybridization and the polymerase chain reaction. Mod Pathol 1994; 7: 113-119.
23. Rebollo A, De Groote D, Baudrihaye M, Thèze J, Jankovict DL. Immunochemical characterization of antigenic domains on human IL-2: spatially distinct epitopes are associated with binding to the p55 and p70 subunits of IL-2 receptor. Mol Immunol 1992; 29: 119-130.
24. De Groote D, Marchant A, Fauchet F, et al. Characterisation of monoclonal antibodies against human interleukin-10 and their use in an ELISA for the measurement of this cytokine. J Immunol Methods 1994; 177: 225-234.
25. Delvenne P, Al-Saleh W, Gilles C, Thiry A, Boniver J. Inhibition of growth of normal and human papillomavirus-transformed keratinocytes in monolayer and organotypic cultures by interferon gamma and tumor necrosis factor alpha. Am J Pathol 1995; 146: 589-598.
26. Spicer SS. A correlation study of the histochemical properties of rodent acid mucopolysaccharides. J Histochem Cytochem 1960; 8: 18-35.
27. Carson LF, Twiggs LB, Fukashima M, Ostrow RS, Faras AJ, Okagaki T. Human genital papilloma infections: an evaluation of immunologic competence in the genital neoplasia-papilloma syndrome. Am J Obstet Gynecol 1986; 155: 784-789.
28. Viac J, Guerin-Reverchon I, Chardonnet Y, Bremond A. Langerhans cells and epithelial cell modifications in cervical intraepitheliai neoplasia: correlation with human papillomavirus infection. Immunobiology 1990; 180: 328-338.
29. McKenzie J, King A, Hare J, Fulford T, Wilson B, Stanley M. Immunocytochemical characterization of large granular lymphocytes in normal cervix and HPV associated disease, J Pathol 1991; 165: 75-80.
30. Coleman N, Stanley MA. Characterization and functional analysis of the expression of vascular adhesion molecules in human papillomavirus-related disease of the cervix. Cancer 1994; 74: 884-892.
31. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 138: 138-147.
32. Kutteh WH, Hatch KD, Blackwell RE, Mestecky J. Secretory immune system of the female reproductive tract. I: Immunoglobulin and secretory component-containing cells. Obstet Gynecol 1988; 71: 56-60.
33. Hordnes K, Tynning T, Kvam Al, Johnsson R, Haneberg B. Colonization in the rectum and uterine cervix with group B streptococci may induce specific antibody responses in cervical secretions of pregnant women. Infect Immun 1996; 64: 1643-1652.
34. Coleman N, Stanley MA. Analysis of HLA-DR expression on keratinocytes in cervical neoplasia. Int J Cancer 1994; 56: 314-319.
35. Al-Saleh W, Delvenne P, Arrese Estrada J, Nikkels AF, Piérard JE, Boniver J. Inverse modulation of intracpithelial Langerhans cells and stromal macrophage/dendrocyte populations in human papillomavirus-associated squamous intraepithelial lesions of the cervix. Virchows Arch 1995; 427: 41-48.
36. Kang K, Kubin M, Cooper KD, Lessin SR, Trinchieri G, Rook AH. IL-12 synthesis by human Langerhans cells. J Immunol 1996; 156: 1402-1407.
37. Aragane Y, Riemann H, Bhardwaj RS, et al. IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines. J Immunol 1994; 153: 5366-5372.
38. Janeway CA, Bottomly K. Signals and signs for lymphocyte response. Cell 1994; 76: 275-285.
39. Tan P, Anasetti C, Hansen JA, et al. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med 1993; 177: 165-173.
40. Straight SW, Herman B, McCance DJ. The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J Virol 1995; 69: 3185-3192.
41. Frazer IH, Immunology of papillomavirus infection. Curr Opin Immunol 1996; 8: 484-491.
42. Seder RA, Paul WE. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 1994; 12: 635-673.
43. Di Girolama W, Goni J, Laguens RP. Langerhans cells in squamous metaplasia of the human uterine cervix. Gynecol Obstet Invest 1985; 19: 38-41.
44. van Driel WJ, Hogendoorn PCW, Jansen F-W, Zwinderman AH, Trimbos JB, Fleuren GJ. Tumor-associated eosinophilic infiltrate of cervical cancer is indicative for a less effective immune response. Hum Pathol 1996; 27: 904-911.